default search action
"Profiling Tox21 Bioassay Towards Drug Repurposing for Rare Diseases."
Fang Liu et al. (2022)
- Fang Liu, Yanji Xu, Jaleal Sanjak, Andrew Patt, Ruili Huang, Chunxu Qu, Qian Zhu:
Profiling Tox21 Bioassay Towards Drug Repurposing for Rare Diseases. AMIA 2022
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.